المؤلفون: Shao Ning Yang, Rabih Slim, Lauren Canova, Andrew J. Murphy, Macdonald Lynn, Jacqueline J. Warsaw, Cagan Gurer, Erica Ullman, Arpita Pawashe, Lauric Haber, Aynur Hermann, Ilyssa Ramos, Gang Chen, Jennifer Stella, Jacquelynn Golubov, Teresa Schulenburg, George D. Yancopoulos, Joel H. Martin, Jennifer Finney, Dimitris Skokos, Ashique Rafique, Elizabeth Navarro, Matthew A. Sleeman, Elena Garnova, Nicole Stokes Oristian, Robert Babb, Xuan Ye, Randi Foster, Julie Kim, William Poueymirou, Qi Wu, Douglas MacDonald, Hassan Ahmed, William C. Olson, Clarissa Lett, Erin Oswald, Janelle C. Waite, Israel Lowy, Stephen Godin, Eric Smith, Pamela Krueger, Devon Grote, Patrick Poon, John C. Lin, Drew Dudgeon, Evan Herlihy, Bei Wang, Amanda Dorvilliers, Dharani Ajithdoss, Jenny Xiao, Christopher Daly, Vishal Kamat, Gavin Thurston, Chia-Jen Siao

المصدر: Science translational medicine. 12(549)

مصطلحات موضوعية: business.industry, medicine.drug_class, medicine.medical_treatment, T-cell receptor, Programmed Cell Death 1 Receptor, CD28, General Medicine, Immunotherapy, Monoclonal antibody, medicine.disease, Mice, Immune system, Antigen, Cancer immunotherapy, CD28 Antigens, Neoplasms, Antibodies, Bispecific, medicine, Cancer research, Animals, Humans, business, Cytokine storm

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9e0670c5d21cb293213bc474b8c8f3
https://pubmed.ncbi.nlm.nih.gov/32581132